60 DEGREES PHARMACEUTICALS, INC. reports

Company location: Washington, DC
Fiscal year end: 31 December

60 DEGREES PHARMACEUTICALS, INC. has filed 217 SEC EDGAR filings since 18 Oct 2022

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 26-44 of 44 matching filings.

Per page

Current page

8-K File 001-41719

FORM 8-K

Filing date: 28 Aug 2024
Reporting date: 26 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 14 Aug 2024
Reporting date: 12 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 12 Aug 2024
Reporting date: 12 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

FORM 8-K

Filing date: 26 Jul 2024
Reporting date: 25 Jul 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 16 Jul 2024
Reporting date: 16 Jul 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 09 Jul 2024
Reporting date: 09 Jul 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 27 Jun 2024
Reporting date: 27 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 12 Jun 2024
Reporting date: 11 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 02 May 2024
Reporting date: 26 Apr 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

FORM 8-K

Filing date: 15 Mar 2024
Reporting date: 15 Mar 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 28 Feb 2024
Reporting date: 27 Feb 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 20 Feb 2024
Reporting date: 13 Feb 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

FORM 8-K

Filing date: 02 Feb 2024
Reporting date: 29 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 22 Jan 2024
Reporting date: 22 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 16 Jan 2024
Reporting date: 10 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 03 Nov 2023
Reporting date: 02 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 12 Oct 2023
Reporting date: 06 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

CURRENT REPORT

Filing date: 18 Sep 2023
Reporting date: 12 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41719

FORM 8-K

Filing date: 17 Jul 2023
Reporting date: 12 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing